You searched for "visual"

2235 results found

OrCam Technologies launches new class of AI reading device

OrCam Technologies, innovator of life-changing, personal 'AI as a companion' solutions, has announced the UK launch of the OrCam Read 3, an all-in-one solution for people with vision loss or reading fatigue, or who find reading challenging.

What effects do repeated Ozurdex implants have in paediatric uveitis?

The aim of this retrospective study was to assess the anatomical and functional results, as well as complications of repeated Ozurdex intravitreal implants in a paediatric (non-infectious) uveitis cohort. Twenty-two eyes (16 patients) received 35 Ozurdex implants over a six...

AI-enabled smart cane scoops award for transforming lives of people with sight loss

An AI-enabled smart cane designed to transform the lives of people with sight loss has won a prestigious international design award. The WeWALK Smart Cane was recognised by the iF International Forum Design at this year’s product design awards. The...

Unilateral cataract extraction outcomes in older children compared to two studies with younger cohorts

The authors present a retrospective study of children undergoing cataract surgery between the ages of two and seven-years-old at one centre, over a 24-year period. Data including demographics, ocular history, ophthalmic findings, operative reports, adverse events, and record of re-operations...

What's trending Dec/Jan 2021

A round-up of the eye-related hot topics that have been trending on social media over the last few weeks. #threeblindmice US company Nanoscope Therapeutics has developed a new treatment which is hoped will restore vision in those affected by retinal...

Toxic nutritional optic neuropathy (TON)

Toxic optic neuropathy are a group of conditions manifested by reduction of visual functions secondary to damage to the anterior visual pathways from exposure to a toxin. The implicated toxin could be work-based, food or drink related, or iatrogenic medication....

Post hoc analysis of the CANTREAT randomised trial

CANTREAT, a Canadian multicentre two-year randomised trial compares treat and extend treatment (T&E) relative to the monthly administration of Ranibizumab in nAMD. Two-hundred and eighty-five treatment-naïve patients with nAMD were randomised to receive either a once-monthly dosing or T&E regimen...

Recognising responsibility, breakthrough design

Celebrating achievements in the international optical world, the 30th anniversary of the Silmo d’Or Awards was a spectacular event. Eyewear designers, international media and senior optical executives and VIPs were welcomed to the underground halls of the Carrousel du Louvre...

Esme’s Umbrella announces the world’s first Charles Bonnet Syndrome Essay Prizes

Esme’s Umbrella (www.charlesbonnetsyndrome) has just announced the world’s first Charles Bonnet Syndrome Essay Prizes.

The bionic eye – behind the headlines

Multiple visual prosthetic projects and other vision regeneration initiatives being tested in preclinical and clinical development worldwide illustrate continuing progress and opportunities in addressing profound blindness from hereditary retinal diseases and other causes (Table 1). Three implantable bionic vision systems...

Irido-corneal endothelial syndrome: an overview

Irido-corneal endothelial (ICE) syndrome is a rare group of eye related disorders that constitute three different clinical entities: Chandler syndrome (CS), essential / progressive iris atrophy and iris naevus / Cogan-Reese syndrome. ICE syndrome is sporadic in its presentation as...

Introducing: the Glaucoma Field Defect Classifier

For patients with advanced glaucoma, there are no treatments to reverse severe sight impairment (blindness). Support in the community is essential but requires a certificate of visual impairment (CVI) signed by a consultant ophthalmologist. The criteria for certification are ambiguous...